Inogen (INGN) Return on Capital Employed Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 252.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -110.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 49.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 658.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -231.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 200.00 |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn | 50.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.00 |
| Dec 31, 2025 | 631.00 |
| Sep 30, 2025 | 1,236.00 |
| Jun 30, 2025 | 2,770.00 |
| Mar 31, 2025 | 2,769.00 |
| Dec 31, 2024 | 2,274.00 |
| Sep 30, 2024 | 2,094.00 |
| Jun 30, 2024 | -930.00 |
| Mar 31, 2024 | -1,382.00 |
| Dec 31, 2023 | -1,876.00 |
| Sep 30, 2023 | -3,824.00 |
| Jun 30, 2023 | -2,790.00 |
| Mar 31, 2023 | -2,766.00 |
| Dec 31, 2022 | -2,502.00 |
| Sep 30, 2022 | -1,060.00 |
| Jun 30, 2022 | -454.00 |
| Mar 31, 2022 | 237.00 |
| Dec 31, 2021 | 508.00 |
| Mar 31, 2021 | -610.00 |
| Dec 31, 2020 | -797.00 |
| Mar 31, 2020 | -686.00 |
| Dec 31, 2019 | -685.00 |
| Sep 30, 2019 | -484.00 |
| Jun 30, 2019 | -427.00 |
| Mar 31, 2019 | -223.00 |
| Dec 31, 2018 | 28.00 |
| Sep 30, 2018 | 13.00 |
| Jun 30, 2018 | 110.00 |
| Mar 31, 2018 | -57.00 |
| Dec 31, 2017 | -48.00 |
| Sep 30, 2017 | 111.00 |
| Jun 30, 2017 | 90.00 |
| Mar 31, 2017 | 211.00 |
| Dec 31, 2016 | 109.00 |
| Sep 30, 2016 | 191.00 |
| Jun 30, 2016 | 140.00 |
| Mar 31, 2016 | 134.00 |
| Dec 31, 2015 | 219.00 |
| Sep 30, 2015 | 170.00 |
| Jun 30, 2015 | 398.00 |
| Mar 31, 2015 | 324.00 |